Table S3. Complete list of signaling pathways dysregulated in patients who failed to complete remission therapy. Signaling pathway analysis was done using MetaCore KPA using the set of 442 genes differentially expressed between good and poor response group. (XLSX 10 kb
Expression levels of immunophenotypic markers in the two groups formed at the extremes of heatmap (g...
Pathways significantly enriched for differentially expressed (DE) genes between TCGA HNSCC progresso...
Point mutation, deep deletion, amplification, shallow deletion, and copy number gain of m6A regulato...
Complete file derived from pathway analysis in patients who failed to remission therapy. Signaling a...
Table S1. Clinical and molecular baseline characteristics of patients. Clinical and molecular data o...
Table S2. Complete set of genes differentially expressed between good (n = 22) versus poor (n = 5) i...
Background: B-Acute lymphoblastic leukemia (B-ALL) represents a hematologic malignancy with poor cli...
Table S1. Patient’s characteristic of gene expression cohort. Table S2. Patient’s characteristic ex ...
Table S4. List of proteins involved in important signaling pathways for BCP-ALL. Shown are proteins ...
Table S5. List of genes that were hypomethylated after CX-4945 incubation (FC<0.25) compared to cont...
Table S6. List of genes that were hypomethylated after combined CX-4945 and DEC incubation (FC<0.25)...
Treatment resulted in a differential expression of 941 genes ( pâ <â0.05). (PDF 256 kb
Figure S1. Supplementary unsupervised hierarchical clustering. Kinase activity profiles of 45 pediat...
Table S2. List of 38 differentially phosphorylated peptides. Thirty-eight peptides were differential...
Figure S2. Absolute phosphorylation intensities of 38 differentially phosphorylated peptides. Superv...
Expression levels of immunophenotypic markers in the two groups formed at the extremes of heatmap (g...
Pathways significantly enriched for differentially expressed (DE) genes between TCGA HNSCC progresso...
Point mutation, deep deletion, amplification, shallow deletion, and copy number gain of m6A regulato...
Complete file derived from pathway analysis in patients who failed to remission therapy. Signaling a...
Table S1. Clinical and molecular baseline characteristics of patients. Clinical and molecular data o...
Table S2. Complete set of genes differentially expressed between good (n = 22) versus poor (n = 5) i...
Background: B-Acute lymphoblastic leukemia (B-ALL) represents a hematologic malignancy with poor cli...
Table S1. Patient’s characteristic of gene expression cohort. Table S2. Patient’s characteristic ex ...
Table S4. List of proteins involved in important signaling pathways for BCP-ALL. Shown are proteins ...
Table S5. List of genes that were hypomethylated after CX-4945 incubation (FC<0.25) compared to cont...
Table S6. List of genes that were hypomethylated after combined CX-4945 and DEC incubation (FC<0.25)...
Treatment resulted in a differential expression of 941 genes ( pâ <â0.05). (PDF 256 kb
Figure S1. Supplementary unsupervised hierarchical clustering. Kinase activity profiles of 45 pediat...
Table S2. List of 38 differentially phosphorylated peptides. Thirty-eight peptides were differential...
Figure S2. Absolute phosphorylation intensities of 38 differentially phosphorylated peptides. Superv...
Expression levels of immunophenotypic markers in the two groups formed at the extremes of heatmap (g...
Pathways significantly enriched for differentially expressed (DE) genes between TCGA HNSCC progresso...
Point mutation, deep deletion, amplification, shallow deletion, and copy number gain of m6A regulato...